Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 60 citing Hoerger: Is glycemic control improving in US adults?. (0.11 sec) 

Differences in control of cardiovascular disease and diabetes by race, ethnicity, …

- angrylapdog.com
… E Meara, AM Zaslavsky, JZ Ayanian - Annals of Internal …, 2009 - annals.org.p.angrylapdog.com
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook Add
to Reddit Add to Technorati Add to Twitter What's this? ... Background: Efforts to improve the care
of cardiovascular disease and ...
Cited by 10 - Related articles - All 7 versions

The utility and recent advances in self-monitoring of blood glucose in type 1 …

- pubget.com [PDF] 
SL Subramanian, IB Hirsch - Diabetes Technology & Therapeutics, 2008 - liebertonline.com
Self-monitoring of blood glucose (SMBG) is a fundamental and effective principle in the man- agement
of type 1 diabetes mellitus (T1DM). SMBG is a precise and accurate clinical tool in the treatment of
glycemia and facilitates tight ...
Cited by 6 - Related articles - BL Direct - All 4 versions

Self-monitoring of blood glucose (SMBG) in insulin-and non-insulin-using adults …

- pubget.com [PDF] 
IB Hirsch, BW Bode, BP Childs, KL Close, WA … - Diabetes Technology …, 2008 - liebertonline.com
DIABETES TECHNOLOGY & THERAPEUTICS Volume 10, Number 6, 2008 © Mary Ann Liebert, Inc. DOI:
10.1089/dia.2008.0104 ... Irl B. Hirsch, MD, 1 Bruce W. Bode, MD, 2 Belinda P. Childs, ARNP-CS,
CDE, BC-ADM,
Cited by 6 - Related articles - All 6 versions

The UKPDS and its global impact.

- nursing2008.com
S Genuth - Diabetic Medicine, 2008 - pt.wkhealth.com
Results: The UKPDS extended to type 2 diabetes and brought to completion the case for linking the
microvascular vascular complications of diabetes to control of blood glucose initially demonstrated
by the Diabetes Control and ...
Cited by 6 - Related articles - All 6 versions

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with …


RE Pratley, MS Kipnes, PR Fleck, C Wilson, … - Diabetes Obes …, 2009 - interscience.wiley.com
Methods: After a 2-week screening period, adult patients 18–80 years of age entered a 4-week
run-in/stabilization period in which they were switched from their own sulphonylurea medication to
an equivalent dose of glyburide ...
Cited by 6 - Related articles - All 3 versions

Clinical application of incretin-based therapy: therapeutic potential, patient …


DM Kendall, RM Cuddihy, RM Bergenstal - European Journal of Internal …, 2009 - Elsevier
Incretin-based therapies address the progressive nature of type 2 diabetes mellitus, not only by
addressing glucose control but also with weight-neutral (ie, dipeptidyl peptidase–4 inhibitors
sitagliptin and vildagliptin) and ...
Cited by 4 - Related articles - All 38 versions

Can Newer Therapies Delay the Progression of Type 2 Diabetes Mellitus?


ES Horton - Endocrine Practice, 2008 - AACE
The global prevalence of diabetes has been increasing in recent decades, reaching near-epidemic
proportions. The number of persons with the disease was estimated at 171 million in the year 2000
and is projected to more than ...
Cited by 4 - Related articles - All 7 versions

The public health response to diabetes--two steps forward, one step back


EW Gregg, AL Albright - JAMA, 2009 - Am Med Assoc
Numerators are derived from the National Hospital Discharge Survey for amputation, the US Renal
Disease System for end-stage renal disease, and the US Vital Statistics System for hyperglycemic
death. Denominators are based on ...
Cited by 3 - Related articles

Clinical pearls and strategies to optimize patient outcomes


SV Joy - The Diabetes Educator, 2008 - tde.sagepub.com
Increasing evidence suggests that a large proportion of patients with type 2 diabetes do not meet
glycemic targets. Early diagnosis, realistic goal setting, improved patient adherence, and a better
understanding of the ...
Cited by 4 - Related articles - All 3 versions

Prevalence and control of diabetes and impaired fasting glucose in New York City


LE Thorpe, UD Upadhyay, S Chamany, R Garg, J … - Diabetes Care, 2009 - Am Diabetes Assoc
RESULTS—The prevalence of diabetes among New York City adults was 12.5% (95% CI 10.3–15.1): 8.7%
diagnosed and 3.8% undiagnosed. Nearly one-fourth (23.5%) of adults had IFG. Asians had the highest
prevalence of impaired glucose ...
Cited by 3 - Related articles - All 3 versions


Result Page: 

1

2

3

4

5

6

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google